DWP14012
DWP14012 is a pharmaceutical drug with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
Treatment Effect According to Timing of Administration of DWP14012 40 mg
Clinical Trials (10)
The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
Treatment Effect According to Timing of Administration of DWP14012 40 mg
Treatment Effect According to Timing of Administration of DWP14012 40 mg
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10